AbCellera Biologics Inc.ABCLNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank63
3Y CAGR-55.7%
5Y CAGR-45.5%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
-55.7%/yr
Quarterly compound
5Y CAGR
-45.5%/yr
Recent deceleration
Percentile
P63
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.70% |
| Q3 2025 | 0.10% |
| Q2 2025 | 109.41% |
| Q1 2025 | 3.80% |
| Q4 2024 | -8.45% |
| Q3 2024 | -0.91% |
| Q2 2024 | -2.11% |
| Q1 2024 | -4.87% |
| Q4 2023 | -4.18% |
| Q3 2023 | -3.90% |
| Q2 2023 | 1.08% |
| Q1 2023 | 1.06% |
| Q4 2022 | 8.08% |
| Q3 2022 | 106.92% |
| Q2 2022 | -8.68% |
| Q1 2022 | 0.53% |
| Q4 2021 | 33.27% |
| Q3 2021 | -9.55% |
| Q2 2021 | 71.29% |
| Q1 2021 | 186.31% |
| Q4 2020 | 14.62% |
| Q3 2020 | -70.68% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |